Stock Price Quote

SUPHA PHARMACHEM LTD.

NSE : NABSE : 539561ISIN CODE : INE549S01036Industry : TradingHouse : Private
BSE0.870.06 (+7.41 %)
PREV CLOSE ( ) 0.81
OPEN PRICE ( ) 0.82
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 6690447
TODAY'S LOW / HIGH ( )0.81 0.90
52 WK LOW / HIGH ( ) 0.693.8
NSE
This Company is not listed in NSE
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1988
Management Info
Rambhajan Vishwakarma - Chairman - Managing Director
Registered Office

Address Office No. 9, K Raheja Prime, Marol Industrial Estate,Behind Ravi Vihar Hotel, Saugbaug Road, Marol,Andheri (East),
Mumbai,
Maharashtra-400059

Phone 8433895251

Email info@remediumlifecare.com

Website www.remlife.com

Registrars Details
Bigshare Services Pvt Ltd
Office No S6-2, 6th Floor, Pinnacle Business Park,Next to Ahura Centre, Mahakali Caves Road,Andheri (E),Mumbai
Listing : BSE

NEWS

22Dec Remedium Lifecare informs about tradin
Remedium Lifecare has informed that in terms of Code of Internal Procedu..
15Dec Supha Pharmachem informs about change
In continuation to its letter dated 22nd September, 2025 and pursuant to..
08Dec Remedium Lifecare informs about notice
Remedium Lifecare has informed that the Company had issued a Postal Ball..
17Nov Remedium Lifecare informs about press
Remedium Lifecare has informed that it enclosed a copy of the press rele..
17Nov Remedium Lifecare informs about newspa
Pursuant to the Regulation 30 of SEBI Listing Regulations, Remedium Life..

Financials

in Millions
QTR Sep 25 ANNUAL 25
Net Profit0.72999999999999415.2999999999999
Gross Profit 0.729999999999994 36.6299999999999
Operating Profit 2.5999999999999989.9099999999999
Net Sales 85.782224.98

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

The Yamuna Syndicate (BSE)
peergroup  27199.00 (0.34%)
M.Cap ( in Cr)836.00
Riddhi Siddhi Gluco (BSE)
peergroup  485.05 (13.07%)
M.Cap ( in Cr)345.83
Ausom Enterprise (BSE)
peergroup  153.50 (19.97%)
M.Cap ( in Cr)209.12
Nanta Tech (BSE)
peergroup  288.30 (9.41%)
M.Cap ( in Cr)147.90
Omnitex Industries (BSE)
peergroup  544.70 (4.44%)
M.Cap ( in Cr)229.00

Shareholding Pattern

NON-INSTITUTION 97.17%
PROMOTERS 1.13%
MUTUAL FUNDS/UTI 0%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%

About Supha Pharmachem Ltd.

Supha Pharmachem Ltd. was incorporated in the year 1988. Its today's share price is 0.87. Its current market capitalisation stands at Rs 76.73 Cr. In the latest quarter, company has reported Gross Sales of Rs. 2224.98 Cr and Total Income of Rs.2333 Cr. The company's management includes Rambhajan Vishwakarma, Vignesh Laxman Gawde, Shamim Adil Michal, Bikram Kumar Mund, Kapil Goplani, Vijay Pal, Dipesh Vaidya, Adarsh Munjal.

It is listed on the BSE with a BSE Code of 539561 , NSE with an NSE Symbol of and ISIN of INE549S01036. It's Registered office is at Office No. 9, K Raheja Prime, Marol Industrial Estate,Behind Ravi Vihar Hotel, Saugbaug Road, Marol,Andheri (East)Mumbai-400059, Maharashtra. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are Anup Kumar Jain & Co, Parshotam & Associates, Taori Sandeep & Associates

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.